ABIN266969
antibody from antibodies-online
Targeting: HSP90AA1
FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA
Antibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [5]
- Immunoprecipitation [1]
- Immunohistochemistry [4]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN266969 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Heat Shock Protein 90kDa alpha (Cytosolic), Class A Member 2 (HSP90AA2) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human, Mouse, Rat, Rabbit, Sheep, Simian
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 0.1 mg
- Storage
- Store at -20°C. Avoid freeze-thaw cycles.
- Handling
- Avoid freeze-thaw cycles
Submitted references Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model.
Inhibiting heat shock protein 90 (HSP90) limits the formation of liver cysts induced by conditional deletion of Pkd1 in mice.
Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease.
KU135, a novel novobiocin-derived C-terminal inhibitor of the 90-kDa heat shock protein, exerts potent antiproliferative effects in human leukemic cells.
A central role for the Hsp90.Cdc37 molecular chaperone module in interleukin-1 receptor-associated-kinase-dependent signaling by toll-like receptors.
Zonal expression of endothelial nitric oxide synthase in sheep and rhesus adrenal cortex.
Localization and characterization of the 86- and 84-kDa heat shock proteins in Hepa 1c1c7 cells.
Deneka AY, Haber L, Kopp MC, Gaponova AV, Nikonova AS, Golemis EA
PloS one 2017;12(4):e0176747
PloS one 2017;12(4):e0176747
Inhibiting heat shock protein 90 (HSP90) limits the formation of liver cysts induced by conditional deletion of Pkd1 in mice.
Smithline ZB, Nikonova AS, Hensley HH, Cai KQ, Egleston BL, Proia DA, Seeger-Nukpezah T, Golemis EA
PloS one 2014;9(12):e114403
PloS one 2014;9(12):e114403
Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease.
Seeger-Nukpezah T, Proia DA, Egleston BL, Nikonova AS, Kent T, Cai KQ, Hensley HH, Ying W, Chimmanamada D, Serebriiskii IG, Golemis EA
Proceedings of the National Academy of Sciences of the United States of America 2013 Jul 30;110(31):12786-91
Proceedings of the National Academy of Sciences of the United States of America 2013 Jul 30;110(31):12786-91
KU135, a novel novobiocin-derived C-terminal inhibitor of the 90-kDa heat shock protein, exerts potent antiproliferative effects in human leukemic cells.
Shelton SN, Shawgo ME, Matthews SB, Lu Y, Donnelly AC, Szabla K, Tanol M, Vielhauer GA, Rajewski RA, Matts RL, Blagg BS, Robertson JD
Molecular pharmacology 2009 Dec;76(6):1314-22
Molecular pharmacology 2009 Dec;76(6):1314-22
A central role for the Hsp90.Cdc37 molecular chaperone module in interleukin-1 receptor-associated-kinase-dependent signaling by toll-like receptors.
De Nardo D, Masendycz P, Ho S, Cross M, Fleetwood AJ, Reynolds EC, Hamilton JA, Scholz GM
The Journal of biological chemistry 2005 Mar 18;280(11):9813-22
The Journal of biological chemistry 2005 Mar 18;280(11):9813-22
Zonal expression of endothelial nitric oxide synthase in sheep and rhesus adrenal cortex.
Peterson JK, Moran F, Conley AJ, Bird IM
Endocrinology 2001 Dec;142(12):5351-63
Endocrinology 2001 Dec;142(12):5351-63
Localization and characterization of the 86- and 84-kDa heat shock proteins in Hepa 1c1c7 cells.
Perdew GH, Hord N, Hollenback CE, Welsh MJ
Experimental cell research 1993 Dec;209(2):350-6
Experimental cell research 1993 Dec;209(2):350-6
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IP
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC